BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9240466)

  • 1. Glutamine235 and arginine272 in human melanocortin 5 receptor determines its low affinity to MSH.
    Frändberg PA; Xu X; Chhajlani V
    Biochem Biophys Res Commun; 1997 Jul; 236(2):489-92. PubMed ID: 9240466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
    Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
    J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, tissue distribution, pharmacology and three-dimensional modelling of melanocortin receptors 4 and 5 in rainbow trout suggest close evolutionary relationship of these subtypes.
    Haitina T; Klovins J; Andersson J; Fredriksson R; Lagerström MC; Larhammar D; Larson ET; Schiöth HB
    Biochem J; 2004 Jun; 380(Pt 2):475-86. PubMed ID: 14965341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonists.
    Haskell-Luevano C; Sawyer TK; Trumpp-Kallmeyer S; Bikker JA; Humblet C; Gantz I; Hruby VJ
    Drug Des Discov; 1996 Dec; 14(3):197-211. PubMed ID: 9017363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alpha-melanotropin.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    Peptides; 2007 May; 28(5):1020-8. PubMed ID: 17376561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites.
    Kopanchuk S; Veiksina S; Petrovska R; Mutule I; Szardenings M; Rinken A; Wikberg JE
    Eur J Pharmacol; 2005 Apr; 512(2-3):85-95. PubMed ID: 15840392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of human melanocortin-5 receptor ligand-receptor interaction.
    Yang Y; Mishra VK; Chen M; Duffee E; Dimmitt R; Harmon CM
    Biochemistry; 2013 Mar; 52(10):1737-45. PubMed ID: 23414113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ligand binding residues in extracellular loops of the melanocortin 1 receptor.
    Chhajlani V; Xu X; Blauw J; Sudarshi S
    Biochem Biophys Res Commun; 1996 Feb; 219(2):521-5. PubMed ID: 8605020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture.
    de Angelis E; Sahm UG; Ahmed AR; Olivier GW; Notarianni LJ; Branch SK; Moss SH; Pouton CW
    Microvasc Res; 1995 Jul; 50(1):25-34. PubMed ID: 7476577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimeric alpha-MSH has increased efficacy to activate the melanocortin MC4 receptor.
    Tiesjema B; Merkestein M; Garner KM; de Krom M; Adan RA
    Eur J Pharmacol; 2008 May; 585(1):24-30. PubMed ID: 18378226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors.
    Lapinsh M; Prusis P; Petrovska R; Uhlén S; Mutule I; Veiksina S; Wikberg JE
    Proteins; 2007 May; 67(3):653-60. PubMed ID: 17357163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of the melanocortin 4 receptor by radioligand binding.
    Schiöth HB; Muceniece R; Wikberg JE
    Pharmacol Toxicol; 1996 Sep; 79(3):161-5. PubMed ID: 8884876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-dependent pharmacological properties of the melanocortin-5 receptor.
    Huang RR; Singh G; Van der Ploeg LH; Fong TM
    J Recept Signal Transduct Res; 2000 Jan; 20(1):47-59. PubMed ID: 10711496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expressions of melanocortin receptor subtypes in melanophores and xanthophores of barfin flounder.
    Kobayashi Y; Tsuchiya K; Yamanome T; Schiöth HB; Takahashi A
    Gen Comp Endocrinol; 2010 Aug; 168(1):133-42. PubMed ID: 20417636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of melanocortin receptor subtypes by radioligand binding analysis.
    Schiöth HB; Muceniece R; Wikberg JE; Chhajlani V
    Eur J Pharmacol; 1995 Feb; 288(3):311-7. PubMed ID: 7774675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.